Synopsis: Diagnosis and treatment of hepatocellular carcinoma in patients with cirrhosis;Diagnostic et traitement du carcinome hépatocellulaire chez les molodes atteints de cirrhose

Gastroenterologie Clinique et Biologique

Volumn 26, Issue 1, 2002, Pages 73-77

  Ganne Carrié, Nathalie ^a   Mohand, Djamila ^a   N'Kontchou, Gisèle ^a   Grando Lemaire, Véronique ^a   Trinchet, Jean Claude ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIANDROGEN; CISPLATIN; DOXORUBICIN; MEGESTROL; OCTREOTIDE; PRAVASTATIN; TAMOXIFEN; VITAMIN D DERIVATIVE;

ARTIFICIAL EMBOLISM; CANCER DIAGNOSIS; CANCER SURGERY; DIAGNOSTIC IMAGING; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PALLIATIVE THERAPY; REVIEW;

EID: 0036185666     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Traitement de l'hypertension portale. Recommandations
2. Antibioprophylaxie de l'infection du liquide d'ascite
3. Augmentation de l'incidence du carcinome hépatocellulaire dans les pays occidentaux. Quelles raisons et quelles conséquences?
4. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: A cost effectiveness analysis
5. Small hepatic nodules in cirrhosis: Ultrasonographic, CT, and MR imaging findings
6. Faut-il biopsier les petits nodules sur foie cirrhotique?
7. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in western patients with cirrhosis
8. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy
9. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma
10. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference
11. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
12. Liver transplantation for hepatocellular carcinoma. Expansion of the tumor size limits does not adversely impact survival
13. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma
14. Locoregional treatments for hepatocellular carcinoma
15. Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection
16. Hepatocellular carcinoma. Radio-frequency ablation of medium and large lesions
17. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates
18. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma
19. La cirrhose est une maladie néoplasique: Étude de la clonalité des micronodules cirrhotiques
20. Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial
21. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma
22. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial
23. Treatment strategy for small hepatocellular carcinoma. Comparison of long-term results after percutaneous ethanol injection therapy and surgical resection
24. Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure
25. Petit carcinome hépatocellulaire isolé chez les patients atteints d'une cirrhose classée Child-Pugh A: Facteurs pronostiques chez 142 patients
26. Faut-il traiter par les antiviraux les malades atteints de cirrhose virale C?
27. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
28. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma. Results of a randomized, controlled trial in a single institution
29. Chemoembolization improves survival in patients with unresectable hepatocellular carcinoma
30. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial
31. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
32. Prospective randomized trial of chemoembolization versus intra-arterial injection of 1-131-labeled-iodized oil in the treatment of hepatocellular carcinoma
33. Tamoxifen in treatment of hepatocellular carcinoma: A randomised controlled trial
34. Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma. Results of a European organization for research and treatment of cancer multicentric double-blind trial
35. Traitement palliatif du carcinome hépatocellulaire par une association d'anti-androgènes (leuproreline + flutamide). Résultats d'un essai multicentrique randomisé
36. Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
37. Treatment of hepatocellular carcinoma with octreotide: A randomised controlled study
38. Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors
39. Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial
40. Screening for hepatocellular carcinoma
41. Vers une chimioprévention du caminome hépatocellulaire?